Eton Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ETON Eton Pharmaceuticals Inc
LXRX Lexicon Pharmaceuticals Inc
BVS Bioventus Inc
TDS-U Telephone and Data Systems Inc
ELEV Elevation Oncology Inc
FRZA Forza X1 Inc
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
GGIFF Garibaldi Resources Corp
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Eton Pharmaceuticals, Inc. is a pharmaceutical company, which is developing, acquiring and commercializing products to address unmet needs in patients suffering from rare diseases. It has three commercial rare disease products, ALKINDI SPRINKLE for the treatment of adrenocortical insufficiency, Carglumic Acid for the treatment of hyperammonemia due to N-acetylglutamate synthase deficiency, and Betaine Anhydrous for the treatment of homocystinuria. It also has three additional product candidates in late-stage development. The Company is developing dehydrated alcohol injection, which has received Orphan Drug Designation for the treatment of methanol poisoning, ZENEO hydrocortisone autoinjector for the treatment of adrenal crisis, and ET-400. Its dehydrated alcohol injection product candidate is under review for the treatment of methanol poisoning. Its ZENEO hydrocortisone autoinjector product candidate is a needle-free autoinjector under development for the treatment of adrenal crisis.

Price
Delayed
$3.87
Day's Change
-0.02 (-0.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.93
Day's Low
3.85
Volume
(Light)

Today's volume of 4,329 shares is on pace to be much lighter than ETON's 10-day average volume of 46,800 shares.

4,329

Uber, Lyft, DoorDash trade group asks for delay of worker-classification rule after Marty Walsh resignation

1:40 pm ET February 17, 2023 (MarketWatch)
Print

By Levi Sumagaysay

Last fall, the department proposed a rule that would change who can be considered an independent contractor instead of an employee

The resignation of Secretary of Labor Marty Walsh this week has prompted the lobbying group that represents Uber Technologies Inc., DoorDash Inc., Lyft Inc. and other gig companies to call for putting off finalizing a proposed Labor Department rule on worker classification.

In October, the department proposed a rule that would change who can be considered an independent contractor or an employee -- returning to a previous test to determine whether workers are actually independent. At the time, Walsh mentioned "many cases" of worker misclassification. The new rule was expected to take effect early this year.

Though gig companies like Uber (UBER), Lyft (LYFT) and DoorDash (DASH) last year reacted to the proposed rule by saying it would not change the classification of their drivers and couriers as independent contractors, their lobbying group Flex is now asking for a delay of the rule's finalization anyway.

"The Department should not finalize its worker classification proposal without a permanent Secretary of Labor who has been nominated by the President and confirmed by the United States Senate," said Kristin Sharp, chief executive of Flex, in a statement Friday.

The Labor Department did not immediately return a request for comment Friday.

See: 'Gig work' rule is in Biden administration's crosshairs

The business model of such app-based platforms relies on treating ride-hailing drivers and delivery workers as independent contractors. Across the nation and around the world, these companies are constantly fighting to keep their workers from being classified as employees. Instead they are advocating for an in-between approach that gives the workers some benefits but not full employee status with benefits such as workers' compensation, sick pay and more.

See: Uber, Lyft get their first legislative win in campaign to write new labor laws

Walsh, a former mayor of Boston and a former union official, on Thursday was named the executive director of the NHL Players' Association and will begin his new role in mid-March. Deputy Secretary Julie Su will become acting secretary under the Labor Department's rules.

-Levi Sumagaysay

	

(END) Dow Jones Newswires

February 17, 2023 13:40 ET (18:40 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.